Publications by authors named "Angelo Reggiani"

Claim this Profile
C
Combined in vivo effect of N-acylethanolamine-hydrolyzing acid amidase and glycogen synthase kinase-3β inhibition to treat multiple sclerosis.
Stefania Sgroi, Elisa Romeo, Ennio Albanesi, Federica Piccardi, Federico Catalano, Angelo Reggiani

Biomed Pharmacother· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human-Induced Pluripotent Stem Cell Technology: Toward the Future of Personalized Psychiatry.
Alessandra Alciati, Angelo Reggiani, Daniela Caldirola, Giampaolo Perna

J Pers Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine.
Rosaria Greco, Chiara Demartini, Anna Maria Zanaboni, Miriam Francavilla, Angelo Reggiani

J Headache Pain· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel potent GSK3 inhibitor AF3581 reverts fragile X syndrome phenotype.
Pier Francesca Porceddu, Mariasole Ciampoli, Elisa Romeo, Beatrice Garrone, Lucia Durando, Angelo Reggiani

Hum Mol Genet· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic.
Alessandro Villa, Electra Brunialti, Jessica Dellavedova, Clara Meda, Monica Rebecchi, Angelo Reggiani

Pharmacol Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic".
Alessandro Villa, Electra Brunialti, Jessica Dellavedova, Clara Meda, Monica Rebecchi, Angelo Reggiani

Pharmacol Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the Mechanism of Action of NAI-112, a Lanthipeptide with Potent Antinociceptive Activity.
Arianna Tocchetti, Marianna Iorio, Zeeshan Hamid, Andrea Armirotti, Angelo Reggiani

Molecules· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of N-acylethanolamine-hydrolyzing acid amidase reduces T cell infiltration in a mouse model of multiple sclerosis.
Stefania Sgroi, Elisa Romeo, Paolo Di Fruscia, Pier Francesca Porceddu, Debora Russo, Angelo Reggiani

Pharmacol Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spinal nociceptive sensitization and plasma palmitoylethanolamide levels during experimentally induced migraine attacks.
Roberto De Icco, Rosaria Greco, Chiara Demartini, Pietro Vergobbi, Annamaria Zanaboni, Angelo Reggiani

Pain· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and SAR Evolution of Pyrazole Azabicyclo[3.2.1]octane Sulfonamides as a Novel Class of Non-Covalent -Acylethanolamine-Hydrolyzing Acid Amidase (NAAA) Inhibitors for Oral Administration.
Paolo Di Fruscia, Anna Carbone, Giovanni Bottegoni, Francesco Berti, Francesca Giacomina, Angelo Reggiani

J Med Chem· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel fragile X syndrome 2D and 3D brain models based on human isogenic FMRP-KO iPSCs.
Carlo Brighi, Federico Salaris, Alessandro Soloperto, Federica Cordella, Silvia Ghirga, Angelo Reggiani

Cell Death Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine.
Rosaria Greco, Chiara Demartini, Annamaria Zanaboni, Ilenia Casini, Roberto De Icco, Angelo Reggiani

Neurobiol Dis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Valeria Capurro, Massimiliano Lanfranco, Maria Summa, Pier Francesca Porceddu, Mariasole Ciampoli, Angelo Reggiani

Biomed Pharmacother· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of Indazole-Based GSK-3 Inhibitors with Mitigated hERG Issue and Activity in a Mood Disorder Model.
Federica Prati, Rosa Buonfiglio, Guido Furlotti, Claudia Cavarischia, Giorgina Mangano, Angelo Reggiani

ACS Med Chem Lett· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FAAH inhibition as a preventive treatment for migraine: A pre-clinical study.
Rosaria Greco, Chiara Demartini, Anna Maria Zanaboni, Elena Tumelero, Angelo Reggiani

Neurobiol Dis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender specific decrease of a set of circulating N-acylphosphatidyl ethanolamines (NAPEs) in the plasma of Parkinson's disease patients.
Zeeshan Hamid, Abdul Basit, Silvia Pontis, Fabrizio Piras, Francesca Assogna, Angelo Reggiani

Metabolomics· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vivo Characterization of ARN14140, a Memantine/Galantamine-Based Multi-Target Compound for Alzheimer's Disease.
Angelo M Reggiani, Elena Simoni, Roberta Caporaso, Johann Meunier, Emeline Keller

Sci Rep· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent α-amino-β-lactam carbamic acid ester as NAAA inhibitors. Synthesis and structure-activity relationship (SAR) studies.
Andrea Nuzzi, Annalisa Fiasella, Jose Antonio Ortega, Chiara Pagliuca, Stefano Ponzano, Angelo Reggiani

Eur J Med Chem· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hit Optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders.
Guido Furlotti, Maria Alessandra Alisi, Nicola Cazzolla, Patrizia Dragone, Lucia Durando, Angelo Reggiani

J Med Chem· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation.
Alison Ribeiro, Silvia Pontis, Luisa Mengatto, Andrea Armirotti, Valerio Chiurchiù, Angelo Reggiani

ACS Chem Biol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A glycosylated, labionin-containing lanthipeptide with marked antinociceptive activity.
Marianna Iorio, Oscar Sasso, Sonia I Maffioli, Rosalia Bertorelli, Paolo Monciardini, Angelo Reggiani

ACS Chem Biol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors.
Stefano Ponzano, Fabio Bertozzi, Luisa Mengatto, Mauro Dionisi, Andrea Armirotti, Angelo Reggiani

J Med Chem· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterization of memoquin, a multi-target compound for the treatment of Alzheimer's disease.
Valeria Capurro, Perrine Busquet, Joao Pedro Lopes, Rosalia Bertorelli, Glauco Tarozzo, Angelo Reggiani

PLoS One· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models.
Oscar Sasso, Guillermo Moreno-Sanz, Cataldo Martucci, Natalia Realini, Mauro Dionisi, Angelo Reggiani

Pain· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity.
João P Lopes, Glauco Tarozzo, Angelo Reggiani, Daniele Piomelli, Andrea Cavalli

Brain Behav· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis